ABSTRACT -Altered mental state is a very common presentation in the elderly admitted to the emergency department. It has been determined that about 16% of patients aged 60 or older with confusion of unknown origin have non-convulsive status epilepticus. The diagnosis of non-convulsive status epilepticus is difficult in the elderly because possible aetiologies of confusion may present with the same clinical picture. Non-convulsive status epilepticus in the elderly carries major morbidity and mortality, attributable primarily to aetiology, and treatment is complex, involving treatment of the aetiology and concomitant medical illnesses, whilst balancing the side effects and drug interactions of antiepileptic drugs.
Non-convulsive status epilepticus (NCSE) Definition and criteria for NCSE
Non-convulsive status epilepticus is a term that covers a range of disparate conditions, denoting prolonged electrographic seizure activity (set arbitrarily at 30 minutes) with resultant non-convulsive clinical symptoms (Walker et al., 2005) . The electrographic seizure activity is divided into clear-cut and equivocal criteria (table 1) . There continues to be difficulties and controversies (equivocal criteria; description number 5 in table 1) with regards to determining EEG abnormal periodic discharges as epiphenomena in severely injured brains or as harmful epileptiform discharges that could lead to additional brain injury. One theory is that periodicity is a surrogate marker for severe cerebral injury and does not cause further brain injury. Another hypothesis is that periodic discharges and seizures in the acutely-injured brain lead to secondary neuronal injury via excessive metabolic demand, excitotoxicity, or other mechanisms (Claassen, 2009 ). Chong and Hirsch (2005) proposed an ictal-interictal injury continuum (figure 1) to put into context the likelihood of neuronal injury for each type of discharge in a given clinical setting in order to guide management (Chong and Hirsch, 2005) . A working definition used in some studies is the Young's criteria in adults (table 2) (Young et al., 1996) . Chong and Hirsch (2005) discussed two caveats of Young's criteria. Firstly, the criteria were intended to be specific to seizures and not necessarily for the purpose of accurate diagnosis. Therefore, a pattern that does not fulfil these criteria The ictal-interictal-injury continuum plot demonstrating various clinico-electrographic diagnoses. The potential for secondary neuronal injury (shown on the y-axis) should be a more important indicator of whether treatment should be aggressive. If clinical correlate is present with any of the patterns, it would be considered ictal by definition, though this does not necessarily suggest an appreciable increase in the likelihood of neuronal injury (Chong and Hirsch, 2005) . EPC: epilepsia partialis continua; GCSE: generalized convulsive status epilepticus; GPEDs: generalized periodic epileptiform discharges; NCS: non-convulsive seizures; NCSE: non-convulsive status epilepticus; PLEDs: periodic lateralized epileptiform discharges; S-B: suppression burst; SIRPIDs: stimulus induced rhythmic, periodic, or ictal discharges; TW: triphasic waves. could still be ictal, but cannot be proven based on the EEG pattern alone. Secondly, regarding number 4 of the secondary criteria ("significant improvement in clinical state or baseline EEG after antiepileptic drugs"), Chong and Hirsch (2005) cited the example of triphasic waves as non-ictal period patterns which are often eradicated with a bolus of benzodiazepines, thus qualifying as a seizure based on Young's criteria. Therefore, more stringent criteria are required in the case of the appearance of previously absent EEG patterns alone to suggest a seizure (table 3) (Chong and Hirsch, 2005 ). This appears to be a stricter set of criteria, to be used in clinical practice and research. There is a need to validate both the Young's and the modified Young's criteria. The Young's and modified Young's working criteria appear to encompass all the criteria (clear-cut and equivocal) presented in table 1. With the secondary criteria (table 3) , it is difficult to provide a consensus on the type and dose of "rapidly acting antiepileptic drugs (AEDs)" used, whether patients should have an immediate or delayed response, and to what degree an improvement is considered "significant".
Epidemiology
The epidemiological data of NCSE is fraught with methodological problems. Attempts to estimate have yielded an overall population incidence of NSCE between 5.6-18.3/100,000/year (from direct epidemiological studies) and 32-85/100,000/year (extrapolation from non-epidemiologically based data) (Walker et al., 2005) .
Classification
The classification of NCSE can be subdivided by age, and further subdivided according to the forms of NCSE observed in epileptic encephalopathies, cerebral development, aetiology and syndrome (Sutter and Table 1 . Criteria for electrographic seizure activity (Walker et al., 2005) .
Criteria Descriptions
Clear-cut criteria (Chong and Hirsch, 2005) .
Criteria EEG features

Primary criteria
Repetitive generalized or focal spikes, sharp waves, spike-and-wave complexes at ≥3/sec._Repetitive generalized or focal spikes, sharp waves, spike-and-wave or sharp-and-slow wave complexes at <3/sec and secondary criterion._Sequential rhythmic, periodic, or quasi-periodic waves at ≥1/sec and unequivocal evolution in frequency (gradually increasing or decreasing by at least 1/sec, e.g. 2 to 3/sec), morphology, or location (gradual spread into or out of a region involving at least two electrodes). Evolution in amplitude alone is not sufficient.
Secondary criteria
Significant improvement in clinical state or appearance of previously absent normal EEG patterns (such as posterior-dominant "alpha" rhythm), temporally coupled to acute administration of a rapidly acting antiepileptic drug. Resolution of the "epileptiform" discharges leaving diffuse slowing without clinical improvement and without appearance of previously absent normal EEG patterns would not satisfy the secondary criterion.
S. Cheng Kaplan, 2012) . Boundary syndromes are a separate subset in which it is unclear to what extent the clinical symptoms are due to NCSE or to underlying cerebral damage/dysfunction. A compendium of EEG patterns observed in NCSE has started to help clarify this classification (Sutter and Kaplan, 2012) .
Neuroimaging and biomarkers
Clinical neuroimaging in NCSE is still limited to computed tomography (CT) or magnetic resonance imaging (MRI) to detect structural abnormalities.
Other imaging techniques including positron emission tomography (PET), single-photon emission computed tomography (SPECT), functional MRI, and perfusion and diffusion imaging are time-dependent, impractical, and have limited sensitivity. Ideally, neuroimaging should detect neuronal changes associated with NCSE and should be comparable, if not superior, to EEG in the diagnosis of NCSE. Biomarkers of neuronal injury, such as neuron-specific enolase, glutamate, glycerol, and lactate-pyruvate ratio may increase after electrographic seizures. Their use is limited, as these analyses are performed on cerebral microdialysis samples. Imaging findings of the interictal-ictal continuum are not well studied, and at best, interpretation is extrapolated from findings observed in convulsive status epilepticus or in the setting of acute brain injury. At this point in time, ancillary testing, such as other neuroimaging techniques and the use of biomarkers mentioned above, could be used in situations where it is equivocal whether the periodic discharges are contributing to additional neuronal injury, to guide aggressive management (Claassen, 2009 ).
Clinico-electrographic features and management
Management guidelines are difficult to establish because of the varied definitions used for NCSE, the heterogeneity of presentations, and outcome measures. Management should include treatment of epileptic discharges, treatment of aetiology, treatment of associated encephalopathy, and treatment of behavioural and cognitive difficulties. I will divide NCSE into three broad scenarios for ease of discussion of management summary guidelines (table 4) (Walker et al., 2005) . There are also many unusual alterations in consciousness, behaviour, and neurological function that can be manifestations of NCSE (Drislane, 2000; Kaplan, 2005) . Drislane (2000) suggested clues to suspect NCSE: occurrence following generalized convulsions or generalized convulsive status epilepticus; subtle signs such as twitching, blinking, and nystagmus in a stuporous patient; otherwise unexplained stupor or confusion, especially in the elderly; altered mental status in the elderly, particularly after benzodiazepine withdrawal; a history of seizures and new medical or surgical stress; and "stroke plus" in patients who appear to fare worse or recover less rapidly than those typically recovering from a stroke.
Prognosis
The prognosis of NCSE is hard to ascertain due to the wide variation in patient presentation and premorbid function, as well as definitions and classifications used, the difficulty in determining duration of NCSE and determining what outcomes are important in prognosis (cognitive, behavioural, morbidity or mortality), the different patient groups studied (age groups, critically ill patients, various co-morbidities, and aetiology of cerebral injury), and the difficulty in differentiating between the morbid effects of treatment and the morbidity of the disease itself (Kaplan, 2005; Walker et al., 2005) . Mortality in NCSE is probably largely a function of NCSE aetiology and relates to a level of consciousness and the development of complications, rather than to a particular type or pattern of EEG. Shneker and Fountain (2003) found that patients presenting with NCSE were associated with high mortality (18%) and morbidity (39%). Mortality due to epilepsy alone was 3%, whereas in those presenting with concomitant brain or systemic injury was 27%. When grouped according to level of consciousness, patients presenting with minimal obtundation had a morbidity and mortality of 7%, whereas those presenting with deep lethargy or coma had morbidity and mortality of 39% (Shneker and Fountain, 2003) . These indicators of mortality were found to be exerting an independent effect. Young et al. (1996) found that mortality is linked strongly to duration and delay to diagnosis of NCSE (Young et al., 1996) . The decision on how rapidly and aggressively to treat NCSE is fundamentally complex. A decision model has been proposed to investigate the interplay of factors influencing NCSE management decisions. Ferguson et al. (2013) have incorporated five variables: baseline mortality rate for specific aetiologies of NCSE, efficacy of non-aggressive treatment, impact of aetiology on outcome, excess disability attributable to delayed seizure control, and mortality risk of aggressive treatment. They then applied the model to four specific aetiologies of NCSE: absence epilepsy, discontinuation/non-compliance of AEDs, intra-parenchymal haemorrhage, and hypoxic ischaemic encephalopathy. The conclusion based on this model is that non-aggressive treatment is favoured for aetiologies with low morbidity and mortality, such 
Epileptic Encephalopathies
This concept reflects the clinical impression that seizures actually alter the course of normal brain development, and is defined based on the following: "the epileptic activity itself may contribute to severe cognitive and behavioural impairments above and beyond what might be expected from the underlying pathology alone and that these can worsen over time".
Treatment is based on the hypothesis that epileptic discharges are causally related to the encephalopathy and therefore treatment of discharges may improve outcome. Pharmacological therapy is used together with behavioural and educational interventions.
2. This term is also used to refer to a group of epilepsy syndromes (chiefly West, Lennox-Gastaut, Dravet, and Landau-Kleffner syndromes, and others) in which the occurrence of seizures and disordered electrographic activity is thought to contribute to the developmental disability commonly observed in these syndromes (Berg and Millichap, 2013) .
S. Cheng as absence epilepsy and discontinuation of antiepileptic drugs. The risk of aggressive treatment is only warranted for aetiologies where there is significant risk of seizure-induced neurological damage (Ferguson et al., 2013) .
Non-convulsive status epilepticus in the elderly
NCSE is often difficult to diagnose in the elderly (aged 60 years and older). This is because of superimposed comorbid medical conditions and medications, and age-related cognitive difficulties that might be blamed when present. This diagnosis thus requires a high degree of suspicion, availability of emergent or continuous EEG, and involvement of neurologists or epileptologists in the diagnosis and management. The causes of NCSE in the elderly can be divided into: -Diseases of the central nervous system, especially cerebrovascular disease (whether acute or remote) and neurodegenerative diseases such as Alzheimer's disease, tumours, and trauma; -Multifactorial, with acute metabolic or infectious precipitants superimposed on an already fragile brain -Exacerbation of earlier epilepsy (Werhahn, 2009) . NCSE in the elderly carries major morbidity and mortality. The mortality rate was reported to be 30% in a group with NCSE compared to a control group without NCSE with a mortality rate of 5.9%. This group of elderly patients with NCSE also had longer periods of hospitalization and poor functional outcome (Bottaro et al., 2007) . In the critically ill elderly patients with NCSE, severity of illness correlated with mortality, and aggressive treatment may not improve outcome (Litt et al., 1998) . Management in the elderly includes treating the aetiology of NCSE, management of the comorbid medical illnesses, and balancing out the side effects and drug interactions of introduced therapies or AEDs. Management is outlined in table 4 with special considerations in the elderly, including decreased tolerability of AED therapy due to age-related changes in pharmacokinetics and pharmacodynamics, the presence of polypharmacy with increased probability of drug-drug interactions or idiosyncratic reactions, and physical and psychiatric comorbidities. (2008)) gives a guideline for dose adjustments accounting for age for patients who present with NSCE fitting into the subtle generalized convulsive status epilepticus type. Most elderly patients remain on AED therapy for life as there is insufficient data to determine whether safe withdrawal of AED therapy can be attempted in the elderly after a period of seizure freedom.
Non-convulsive status epilepticus as a cause of altered mental states in the elderly
It is difficult to determine the prevalence of NCSE in patients presenting with acute altered mental states (AMS) whose cause cannot be quickly determined, as designs of the study have varied. At the moment, prevalence is reported to be between 8 and 30% from indirect sources, with two of these studies performed in the elderly population (Alroughani et al., 2009; Veran et al., 2010; Zehtabchi et al., 2011; Shavit et al., 2012) . To allow comparison between similar populations, there is a need to : -Standardize definitions of NCSE used in the various studies. The modified Young's criteria appear more stringent than the Young's criteria.
-Prospectively enrol consecutive patients presenting with AMS; up to 53% of patients were not suspected to have NCSE by treating physicians (Seidel et al., 2012) , therefore consecutive patients should be enrolled.
-Have larger sample sizes.
-Decide on the duration of EEG recording and monitoring and how quickly from presentation this should be performed. For example, is a routine 20-minute EEG shortly after presentation to the emergency department (within an hour) adequate? Is a continuous EEG (duration of 24-48 hours) within 72 hours of presentation the gold standard? Would this "gold standard" result in a delay in the diagnosis of NCSE by 72 hours? It is recommended that in non-comatose patients, at least 24 hours of continuous EEG should be performed, and in comatose patients, at least 48 hours is required (Claassen et al., 2004) . Issues in delays in obtaining an EEG, especially after several hours or a weekend, also need to be addressed.
-Validate cases with particular attention to inter-rater reliability of EEG interpretation.
-Define premorbid functional status.
-Define outcome measures which are practical and clinically relevant (medium and long-term cognitive and behavioural outcomes are important outcome measures aside from morbidity and mortality).
-Analyze "pure" populations of patients with the same eventual NCSE syndrome and same underlying aetiology.
There have been attempts to determine clinical features that could predict NCSE. In an adult population (aged 15-89 years of age), remote risk factors for seizures, a depressed mental state, and ocular movement abnormalities were more common in patients in the NCSE group (Husain et al., 2003) . In the elderly population (≥60 years of age) who present with confusion of unknown origin, female gender, rapid onset (<24 hours), and a lack of response to simple
Non-convulsive status epilepticus in the elderly Table 5 . Drug dosing for NCSE; adjusting for age in the case of subtle generalized convulsive status epilepticus.
Drug Dosing
A) First-line (adequate respiratory and blood pressure support must be available) commands appear to be statistically more frequent in the NCSE group compared to the non-epileptic confusion group (Veran et al., 2010 ).
Lorazepam
An ideal EEG system
Since a high degree of suspicion and the prompt use of EEG are required to detect NCSE in elderly patients who present with AMS, emergency EEG systems have been proposed to be used in acute care settings ). An abbreviated EEG (with a duration of five minutes) using a preformed electrode placement pattern has been suggested to be incorporated into the early workup of patients who present with AMS of unknown cause, to provide useful and immediate information without interrupting the routine workup of these patients in the emergency department (Bautista et al., 2007) . In this study, the results from the abbreviated EEG were not compared with those of routine or continuous EEG monitoring as the "gold standard". It could be ideal and cost effective to use an initial abbreviated EEG at presentation, together with clinical features, to predict patients with NSCE, or to risk stratify patients in order to then perform a routine or continuous EEG for those identified by the abbreviated EEG as being at high risk of developing NCSE. Periodic lateralised epileptiform discharges (PLEDs), generalized periodic epileptiform discharges (GPEDs), and suppression burst were frequently observed in patients with seizures on continuous EEG monitoring and could be used as EEG indicators to risk stratify patients at high risk (Claassen et al., 2004) . In patients with seizures, there appeared to be a transition from PLEDs-proper to PLEDs-plus, to seizure, with a cycle back to PLEDs-proper. Therefore, patients with PLEDsplus detected by EEG were more likely to have a seizure during the acute illness compared to patients with solely PLEDs-proper (Chong and Hirsch, 2005) . A survey of neurologists' use of EEG monitoring demonstrated that there is significant variation in terms of continuous EEG indications, initiation of urgent treatment, duration and frequency of review, and management of NCSE. This indicates that there is a need to clarify the optimal use of continuous EEG and the treatment of NCSE (Abend et al., 2010) . Continuous EEG monitoring has been shown to have a significant effect on clinical decision-making, in terms of the need for an AED and the effect of prescribed AED therapy in real time (Kilbride et al., 2009; Seidel et al., 2012) . An increase in the implementation of continuous EEG could correspond to an increase in NCSE diagnosis. In the traditional setting, continuous EEG recordings generate huge amounts of data and are reviewed by an experienced encephalographer periodically. Analytical tools, such as quantitative EEG and compressed EEG pattern analysis, may be capable of alerting physicians of ongoing electrographic seizure activity (Shah et al., 2006; Brenner, 2009 ). There can be many challenges when monitoring EEG continuously in the intensive care setting .
Future directions
At present, there are many unanswered questions. There is a need for a prospective study to determine the prevalence of NCSE, specifically consecutive elderly patients who present with AMS, in order to investigate a population ranging from patients in the community presenting with acute confusion to patients in intensive care in a coma. There probably is a need also to look at the prevalence of NCSE due to specific aetiologies in the elderly, as NCSE associated with sepsis is different from NCSE in patients with a remote history of epilepsy. Clinical features should be identified in these elderly patients, which would predict NCSE with adequate sensitivity and specificity. Management guidelines on the duration and cost effectiveness of emergency and abbreviated EEGs in the context of investigating these elderly patients who present with AMS should also be developed. It also remains unclear what the prognosis of NCSE is, independent of the primary aetiology. If NCSE in the elderly does not contribute to a worse outcome, then there is less need to subject an elderly patient to aggressive treatment of NCSE, which would more likely contribute to iatrogenic complications. A decision analysis tool has been proposed to weigh the benefits and risks of aggressive treatment with the morbidity and mortality of NCSE and the primary aetiology.
Conclusion
In an ideal scenario, elderly patients with altered mental states would undergo an array of investigations, performed routinely in the emergency department without delay. NCSE could be detected on the initial emergent EEG, and together with other neuroimaging and biochemical investigations, the aetiology of the NCSE might be determined and then a decision made regarding the appropriate treatment. The treatment plan could be analyzed for risk and benefits with the aid of a decision analysis tool.
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